Center for Advancing COVID-19 health Equity Research

推进 COVID-19 健康公平研究中心

• 批准号: 10532596
• 负责人: Jocelyn D Spates
• 金额: $ 70.73万
• 依托单位: FLORIDA AGRICULTURAL AND MECHANICAL UNIV
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-04-01 至 2024-09-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10532596
• 关键词: Center; Advancing; COVID; 19; health

PROJECT SUMMARY Minority enrollment in clinical trials is essential as it allows scientists to evaluate the safety and efficacy of medical products, including medications, vaccines, and devices within these genetically/ethnically diverse populations. Despite this, minority participation in clinical trials remains low. The overall goal of this grant proposal is to investigate possible causes of low enrollment of racial and ethnic minority populations in COVID-19/COVID-19 variant clinical trials and determine solutions to overcome low enrollment. Over the years, the College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health has developed strong collaborative relationships with organizations such as Northeast Florida Medical Society, William Gunn’s Medical Society, Turner Alliance Consulting, and East Coast Research Institute. In this proposed investigation, we will partner with these organizations to focus on three specific aims 1) Identify the major gaps in the local communities that contribute to the low enrollment of racial and ethnic minority populations in COVID-19 clinical trials, 2) Develop, pilot, and evaluate a community- based targeted strategy to actively improve the enrollment of the racial and ethnic minority population in local COVID-19 clinical trials and 3) Provide Clinical Research Fastrack training for 30 minority healthcare providers and workers in three geographic areas (Jacksonville, Tampa, Tallahassee, FL). The investigators will conduct qualitative interviews with the community, healthcare providers, and community leaders to discuss strategies/education methods to increase enrollment for minority populations in clinical trials and identify health advisors/ambassadors to conduct educational sessions for the community focusing on COVID-19 clinical trials. A website containing clinical trial information and frequently asked questions will be developed along with billboards with website information. The expected outcome of this proposed study is to identify the possible causes of low enrollment of racial and ethnic minority populations in COVID- 19/COVID-19 variant clinical trials. Our major goal is to develop a workable model to increase awareness and participation of minorities in COVID-19/COVID-19 variant clinical research trials.

项目总结 少数人参加临床试验是至关重要的，因为它允许科学家评估安全性和 医疗产品的功效，包括药物、疫苗和设备 遗传/种族多样化的人群。尽管如此，少数人参与了临床试验 仍然很低。这项拨款提案的总体目标是调查低收入的可能原因。 新冠肺炎/新冠肺炎变异临床试验中种族和少数民族人群的招募 并确定解决方案，以克服入学率低的问题。多年来，药学院 与药学、公共卫生研究所开展了强有力的合作 与佛罗里达东北部医学会等组织的关系，威廉·冈恩 医学学会、特纳联盟咨询公司和东海岸研究所。在本建议中 调查中，我们将与这些组织合作，重点关注三个具体目标1)确定 造成种族和民族入学率低的地方社区的主要差距 新冠肺炎临床试验中的少数族裔人群，2)开发、试点和评估社区- 立足有针对性的战略，积极提高民族和少数民族的入学率 参与当地新冠肺炎临床试验的人群和3)为以下人群提供临床研究培训 三个地理区域(杰克逊维尔、坦帕、 佛罗里达州塔拉哈西)调查人员将与社区进行定性访谈， 医疗保健提供者和社区领导人讨论战略/教育方法 招募少数群体参加临床试验，并确定健康顾问/大使以 为社区举办以新冠肺炎临床试验为重点的教育课程。一个网站 包含临床试验信息和常见问题的开发将与 带有网站信息的广告牌。 这项拟议研究的预期结果是确定 COVID中种族和少数民族人口入学率低的可能原因-- 19/新冠肺炎变异临床试验。我们的主要目标是开发一种可行的模式来增加 少数民族对新冠肺炎/新冠肺炎变异临床研究试验的认识和参与